Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
590,231,680
-
Total 13F shares
-
172,698,470
-
Share change
-
+5,307,817
-
Total reported value
-
$31,904,145,015
-
Put/Call ratio
-
96%
-
Price per share
-
$184.74
-
Number of holders
-
900
-
Value change
-
+$968,811,426
-
Number of buys
-
373
-
Number of sells
-
432
Institutional Holders of Edwards Lifesciences Corp - Common Stock (EW) as of Q2 2019
As of 30 Jun 2019,
Edwards Lifesciences Corp - Common Stock (EW) was held by
900 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
172,698,470 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, FMR LLC, SANDS CAPITAL MANAGEMENT, LLC, Bank of New York Mellon Corp, JENNISON ASSOCIATES LLC, Capital Research Global Investors, WELLINGTON MANAGEMENT GROUP LLP, and ALLIANCEBERNSTEIN L.P..
This page lists
905
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.